ADVFN US – Market Content Editor
-
Novo Nordisk Adopts Novo as Everyday Operating Name and Introduces New Cultural Framework
Novo Nordisk (NYSE:NVO) announced a corporate rebranding initiative under which it will use “Novo” as its everyday operating name while retaining Novo Nordisk A/S as its legal global company name. The pharmaceutical company also introduced a new tagline, “Lasting Health Starts Now,” alongside a cultural framework called “The Novo Way.” The updated visual identity will…
-
Elmet Group Secures $450 Million US Government Investment to Expand Tungsten Supply Chain
The Elmet Group Co. (NASDAQ:ELMT) said on September 14, 2026, that the US Department of War has committed to invest $450 million in the company to expand domestic tungsten manufacturing and international mining capacity. The investment will begin with an initial $200 million drawdown at closing, followed by additional drawdowns. In return, the department will…
-
Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results
Olema Pharmaceuticals (NASDAQ:OLMA) shares fell 15.1% in pre-market trading to $8.68 after AstraZeneca reported that its Phase 3 SERENA-4 trial of camizestrant did not meet its primary endpoint. AstraZeneca said on Friday that camizestrant, in combination with palbociclib, did not demonstrate a statistically significant improvement in progression-free survival as a first-line treatment for patients with…
-
Fluor Shares Rise 6.1% Following Earnings Beat and Analyst Actions
Fluor (NYSE:FLR) shares rose 6.1% in pre-market trading to $57.52, putting the engineering and construction company’s stock close to its 52-week high of $58.35. The supplied information did not identify a new company announcement on Monday to account for the move. The advance followed recent analyst actions and Fluor’s second-quarter 2026 financial results. Truist Raises…
-
Scholar Rock Shares Rise 9.1% After FDA Approves ISEMBYLD for Spinal Muscular Atrophy
Scholar Rock Holding Corp (NASDAQ:SRRK) shares rose 9.1% in pre-market trading to $60.45 after the US Food and Drug Administration approved ISEMBYLD (apitegromab-mstn) for the treatment of spinal muscular atrophy. The treatment was approved for adults and children aged two years and older who are receiving an SMN2-targeted therapy. According to the supplied information, ISEMBYLD…
-
IREN Shares Fall 2.7% as Technology Stocks Decline
IREN (NASDAQ:IREN) shares fell 2.7% in pre-market trading to $42.65 as technology and AI infrastructure stocks declined alongside the broader US equity market. The supplied information did not identify a new company-specific announcement behind Monday’s decline. The move followed a rise of approximately 23% in IREN shares over the previous five trading sessions. The recent…
-
MARA Holdings Shares Fall 5.7% After JPMorgan Double Downgrade
MARA Holdings (NASDAQ:MARA) shares fell 5.7% in pre-market trading to $11.30 after JPMorgan downgraded the Bitcoin mining company to Underweight from Neutral and lowered its price target. JPMorgan cut its target to $11 from $13 and extended the target horizon to December 2027. The bank cited MARA’s capital-light strategy through its joint venture with Starwood…
-
Applied Materials Shares Fall 5.8% as Semiconductor Stocks Decline
Applied Materials (NASDAQ:AMAT) shares fell 5.8% in pre-market trading on Monday to $430 as US semiconductor stocks declined following calls from technology executives for a slower pace of advanced artificial intelligence development. The move extended a decline in Applied Materials shares following the company’s fiscal third-quarter 2026 earnings report in August. The supplied information did…
-
AMD Shares Fall 5.6% as AI Development Debate Weighs on Semiconductor Stocks
Advanced Micro Devices (NASDAQ:AMD) shares fell 5.6% in pre-market trading on Monday to $487.07 as semiconductor stocks declined following calls from US technology executives for a slower pace of advanced artificial intelligence development. Investors were assessing whether a change in the pace of AI development could affect future infrastructure spending and demand for semiconductor products.…
-
SanDisk Shares Fall 5.5% as AI Demand Concerns Weigh on Memory Stocks
SanDisk Corporation (NASDAQ:SNDK) shares fell 5.5% in pre-market trading on Monday to $1,543.92 as semiconductor and memory stocks declined amid renewed investor assessment of demand associated with artificial intelligence infrastructure. US chip stocks broadly moved lower after technology executives called for a slower pace of advanced AI development because of safety concerns. Investors were also…